DK0873752T3 - Vandigt oplösningsmiddel-baseret indkapsling af vaccine af en bovint herpesvirus type-1-underenhed - Google Patents

Vandigt oplösningsmiddel-baseret indkapsling af vaccine af en bovint herpesvirus type-1-underenhed

Info

Publication number
DK0873752T3
DK0873752T3 DK98302863T DK98302863T DK0873752T3 DK 0873752 T3 DK0873752 T3 DK 0873752T3 DK 98302863 T DK98302863 T DK 98302863T DK 98302863 T DK98302863 T DK 98302863T DK 0873752 T3 DK0873752 T3 DK 0873752T3
Authority
DK
Denmark
Prior art keywords
subunit
aqueous solvent
based vaccine
herpesvirus type
bovine herpesvirus
Prior art date
Application number
DK98302863T
Other languages
English (en)
Inventor
Manuel Campos
Patrick Frenchick
Frederick Clark
Paul Offit
Charlotte Moser
Tully Speaker
Original Assignee
Pfizer
Univ Temple
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Univ Temple, Philadelphia Children Hospital filed Critical Pfizer
Application granted granted Critical
Publication of DK0873752T3 publication Critical patent/DK0873752T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK98302863T 1997-04-23 1998-04-14 Vandigt oplösningsmiddel-baseret indkapsling af vaccine af en bovint herpesvirus type-1-underenhed DK0873752T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4417297P 1997-04-23 1997-04-23

Publications (1)

Publication Number Publication Date
DK0873752T3 true DK0873752T3 (da) 2004-05-10

Family

ID=21930892

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98302863T DK0873752T3 (da) 1997-04-23 1998-04-14 Vandigt oplösningsmiddel-baseret indkapsling af vaccine af en bovint herpesvirus type-1-underenhed

Country Status (15)

Country Link
US (1) US6270800B1 (da)
EP (1) EP0873752B1 (da)
JP (1) JPH10316586A (da)
CN (1) CN1196931A (da)
AR (1) AR012009A1 (da)
AT (1) ATE262324T1 (da)
AU (1) AU713639B2 (da)
BR (1) BR9801435A (da)
CA (1) CA2229430A1 (da)
DE (1) DE69822542T2 (da)
DK (1) DK0873752T3 (da)
ES (1) ES2216242T3 (da)
NZ (1) NZ330251A (da)
PT (1) PT873752E (da)
ZA (1) ZA983327B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
CA2361377C (en) * 1999-02-05 2009-02-03 Alk-Abello A/S Novel mucosal delivery system
KR20010003853A (ko) * 1999-06-25 2001-01-15 박호군 경구용 백신으로 사용할 수 있는 알긴산염 마이크로스피어 및그 제조방법
US7037681B2 (en) * 2000-02-08 2006-05-02 University Of Hawaii Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
US20030100106A1 (en) * 2000-02-08 2003-05-29 Chang Sandra P. Baculovirus produced Plasmodium falciparum vaccine
JP4370451B2 (ja) * 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
WO2006063030A1 (en) * 2004-12-08 2006-06-15 Speaker Tycho J Microencapsulation product and process
CN104302279A (zh) * 2012-05-10 2015-01-21 聚和国际股份有限公司 用于制备微胶囊的组合物及用其所制得的药物
EP3003287B1 (en) 2013-05-28 2021-04-28 Capsulent Method and microcapsules for treating split ends in hair
CN107973840A (zh) * 2017-01-13 2018-05-01 浙江海隆生物科技有限公司 CHO细胞表达牛传染性病气管炎病毒gD蛋白及其亚单位疫苗的制备和应用
CN112180089A (zh) * 2020-09-21 2021-01-05 黑龙江八一农垦大学 一种牛疱疹病毒i型抗体阻断elisa检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
US5462734A (en) * 1990-11-02 1995-10-31 Wisconsin Alumni Research Foundation Bovine herpesvirus vaccine and method of using same
JPH10500889A (ja) * 1994-04-15 1998-01-27 テンプル・ユニバーシティ 水性溶媒封入法、装置およびマイクロカプセル
US5686113A (en) * 1995-03-21 1997-11-11 Temple University Of The Commonwealth System Of Higher Education Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses

Also Published As

Publication number Publication date
BR9801435A (pt) 2000-01-11
EP0873752B1 (en) 2004-03-24
DE69822542T2 (de) 2004-08-05
AU713639B2 (en) 1999-12-09
EP0873752A2 (en) 1998-10-28
CN1196931A (zh) 1998-10-28
CA2229430A1 (en) 1998-10-23
AU6351198A (en) 1998-11-12
JPH10316586A (ja) 1998-12-02
DE69822542D1 (de) 2004-04-29
ZA983327B (en) 1999-10-21
NZ330251A (en) 1998-11-25
EP0873752A3 (en) 2001-02-07
AR012009A1 (es) 2000-09-13
ATE262324T1 (de) 2004-04-15
PT873752E (pt) 2004-07-30
US6270800B1 (en) 2001-08-07
ES2216242T3 (es) 2004-10-16

Similar Documents

Publication Publication Date Title
ATE197406T1 (de) Influenza vaccine
IL181468A (en) E2 subunit vaccine comprising recombinant pestivirus e2 protein
NO20003302L (no) Vaksine
FR2799362B1 (fr) Prothese a collerette
NO20002653L (no) Sementeringshjelpemidler
DE60033930D1 (de) Emulation einer geräteabschaltung
DK1146794T3 (da) Et hypoallergenisk præparat indeholdende tolerogeniske peptider, der inducerer oral tolerance
NO992667L (no) Ny human <beta>2-integrin-<alfa>-subenhet
FI970277L (fi) Influenssavirusalayksikön konjugaatteja
NO20024443D0 (no) Limsystem omfattende eteriserte aminoharpikser
PT873752E (pt) Encapsulacao com base em solvente aquoso de uma vacina de uma subunidade do virus do herpes bovino de tipo-1
ATE519775T1 (de) Rekombinante untereinheiten-impfstoffe
DE59909604D1 (de) Prothesensystem
KR970052570U (ko) 프로젝션(projection) 시계
BR1100968A (pt) Formulação de vacina de subunidade
IT1298090B1 (it) Dispositivo di marcatura
BR1100630A (pt) Composição de uma vacina
BR1100918A (pt) Composição de vacina contendo adjuvantes
ATE540627T1 (de) Externes fixiersystem
UA3699S (uk) Комплект етикеток
UA3176S (uk) Комплект етикеток
UA3868S (uk) Комплект етикеток
UA3700S (uk) Комплект етикеток
UA3299S (uk) Комплект етикеток
UA3351S (uk) Комплект етикеток